Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more
Medivie Therapeutic Ltd (MDVI) - Total Assets
Latest total assets as of June 2021: ILA4.67 Million ILA
Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) holds total assets worth ILA4.67 Million ILA as of June 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medivie Therapeutic Ltd - Total Assets Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medivie Therapeutic Ltd - Asset Composition Analysis
Current Asset Composition (December 2020)
Medivie Therapeutic Ltd's total assets of ILA4.67 Million consist of 41.6% current assets and 58.5% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 34.0% |
| Accounts Receivable | ILA759.00K | 6.2% |
| Inventory | ILA101.00K | 0.8% |
| Property, Plant & Equipment | ILA5.77 Million | 47.3% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medivie Therapeutic Ltd's current assets represent 41.6% of total assets in 2020, a decrease from 76.0% in 2010.
- Cash Position: Cash and equivalents constituted 34.0% of total assets in 2020, down from 46.6% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2010.
- Asset Diversification: The largest asset category is property, plant & equipment at 47.3% of total assets.
Medivie Therapeutic Ltd Competitors by Total Assets
Key competitors of Medivie Therapeutic Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Al-Ghazi Tractors Ltd
KAR:AGTL
|
Pakistan | PKRs17.88 Billion |
|
Bosung Power Technology Co. Ltd
KQ:006910
|
Korea | ₩135.72 Billion |
|
Youngsin Metal Industrial Co. Ltd
KQ:007530
|
Korea | ₩147.89 Billion |
|
SMCore.Inc
KQ:007820
|
Korea | ₩111.26 Billion |
|
Heungkuk Metaltech Co.Ltd
KQ:010240
|
Korea | ₩134.35 Billion |
|
Nuintek Co.Ltd
KQ:012340
|
Korea | ₩79.96 Billion |
|
CAS Corporation
KQ:016920
|
Korea | ₩171.45 Billion |
|
Semyung Electric Machinery Co.Ltd
KQ:017510
|
Korea | ₩107.57 Billion |
Medivie Therapeutic Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Medivie Therapeutic Ltd generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Medivie Therapeutic Ltd is currently not profitable relative to its asset base.
Medivie Therapeutic Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.36 | 0.92 | 2.21 |
| Quick Ratio | 0.36 | 0.90 | 2.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-5.64 Million | ILA -564.00K | ILA 1.16 Million |
Medivie Therapeutic Ltd - Advanced Valuation Insights
This section examines the relationship between Medivie Therapeutic Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.59 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -9.6% |
| Total Assets | ILA12.19 Million |
| Market Capitalization | $135.65K USD |
Valuation Analysis
Below Book Valuation: The market values Medivie Therapeutic Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Medivie Therapeutic Ltd's assets decreased by 9.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Medivie Therapeutic Ltd (2010–2020)
The table below shows the annual total assets of Medivie Therapeutic Ltd from 2010 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | ILA12.19 Million | -9.62% |
| 2019-12-31 | ILA13.49 Million | -18.23% |
| 2018-12-31 | ILA16.50 Million | -16.30% |
| 2017-12-31 | ILA19.71 Million | +727.54% |
| 2016-12-31 | ILA2.38 Million | +312.11% |
| 2015-12-31 | ILA578.00K | -85.48% |
| 2014-12-31 | ILA3.98 Million | +655.22% |
| 2013-12-31 | ILA527.00K | -80.32% |
| 2012-12-31 | ILA2.68 Million | -79.58% |
| 2011-12-31 | ILA13.12 Million | +239.59% |
| 2010-12-31 | ILA3.86 Million | -- |